Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets
Abstract Tuberculosis remains a serious threat to human health world-wide, and improved efficiency of medical treatment requires a better understanding of the pathogenesis and the discovery of new drugs. In the present study, we performed a whole-cell based screen in order to complete the characteri...
Guardado en:
Autores principales: | Valentin Trofimov, Sébastien Kicka, Sabrina Mucaria, Nabil Hanna, Fernando Ramon-Olayo, Laura Vela-Gonzalez Del Peral, Joël Lelièvre, Lluís Ballell, Leonardo Scapozza, Gurdyal S. Besra, Jonathan A. G. Cox, Thierry Soldati |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/083087377a9442d89e1c1d4ec18b7f01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Social amoebae trap and kill bacteria by casting DNA nets
por: Xuezhi Zhang, et al.
Publicado: (2016) -
Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.
por: Sophie Gryseels, et al.
Publicado: (2012) -
Bloodstream infections with rapidly growing nontuberculous mycobacteria
por: Isin Yagmur Comba, et al.
Publicado: (2021) -
Talaromyces marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients
por: Ye Qiu, et al.
Publicado: (2021) -
Evaluation of antimycobacterial activity from marine and freshwater microalgae
por: Ruiz-Güereca,Duahmet A., et al.
Publicado: (2019)